Cytokine and Visual Outcome Variations in Eyes Receiving Ranibizumab
NCT03056092
·
clinicaltrials.gov ↗
PHASE4
Phase
UNKNOWN
Status
168
Enrollment
OTHER
Sponsor class
Conditions
Age Related Macular Degeneration
Diabetic Macular Edema
Macular Edema
Retinal Vein Occlusion
Interventions
DRUG:
Intravitreal ranibizumab
Sponsor
Unity Health Toronto